Bernstein Harold sold MAZE

December 29, 2025 · Form 4 insider transaction

Bernstein Harold sold 17,200 shares of Maze Therapeutics, Inc. at $40.93 per share, a transaction worth $703.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
17,200
Price
$40.93
Total value
$703.9K
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 29, 2025
Filing dateDecember 31, 2025
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.73 to $41.51 per share, inclusive.

View the original Form 4 on SEC EDGAR